Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mokan, M.
Right arrow Articles by Gerich, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mokan, M.
Right arrow Articles by Gerich, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 17, Issue 12 1397-1403, Copyright © 1994 by American Diabetes Association


ARTICLES

Hypoglycemia unawareness in IDDM

M Mokan, A Mitrakou, T Veneman, C Ryan, M Korytkowski, P Cryer and J Gerich
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania.

OBJECTIVE--To assess the characteristics of patients with hypoglycemia unawareness (development of neuroglycopenia without appropriate prior autonomic warning symptoms) and its predisposing factors. RESEARCH DESIGN AND METHODS--We studied 43 insulin-dependent diabetes mellitus patients who were objectively categorized as having or not having hypoglycemia using the stepped hypoglycemic clamp technique in which plasma glucose was clamped at plateaus of 4.3, 3.6, 3.0, and 2.3 mmol/l and a statistical criterion (onset of autonomic warning symptoms at a plasma glucose concentration 2 SD below normal) and examined their clinical characteristics and hormonal, symptomatic, and cognitive responses. RESULTS--Eleven (26%) of the patients were classified as having hypoglycemia unawareness. Compared with the other patients, unaware patients had a lower HbA1c level (P < 0.01), a longer duration of diabetes (P < 0.01), and a history of more severe hypoglycemia (P < 0.003). During experimental hypoglycemia, counterregulatory hormone responses, neuroglycopenic symptoms, and cognitive dysfunction all began at lower plasma glucose concentrations in unaware patients (P < 0.01, 0.03, and 0.01, respectively). Moreover, although the magnitudes of their plasma catecholamine responses and autonomic symptoms were reduced (both, P < 0.01), the plasma catecholamine levels at which autonomic symptoms began was not altered. Finally, as seen from glucose infusion rates necessary to maintain identical plasma glucose levels, patients with hypoglycemia unawareness had increased sensitivity to insulin (P < 0.001). CONCLUSIONS--Our results confirm an association between hypoglycemia unawareness and duration of diabetes, glycemic control, and occurrence of severe hypoglycemia, and in addition provide evidence that both autonomic and neuroglycopenic symptoms are affected and that insulin sensitivity is increased, but beta-adrenergic sensitivity is not diminished.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
X. Fan, Y. Ding, H. Cheng, D. X. Gram, R. S. Sherwin, and R. J. McCrimmon
Amplified Hormonal Counterregulatory Responses to Hypoglycemia in Rats After Systemic Delivery of a SUR-1-Selective K+ Channel Opener?
Diabetes, December 1, 2008; 57(12): 3327 - 3334.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. N. Zammitt, R. E. Warren, I. J. Deary, and B. M. Frier
Delayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes: Effect of Impaired Awareness of Hypoglycemia
Diabetes, March 1, 2008; 57(3): 732 - 736.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Cheng, L. Zhou, W. Zhu, A. Wang, C. Tang, O. Chan, R. S. Sherwin, and R. J. McCrimmon
Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E705 - E712.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. E. de Galan, S. J. Rietjens, C. J. Tack, S. P. van der Werf, C. G. J. Sweep, J. W. M. Lenders, and P. Smits
Antecedent Adrenaline Attenuates the Responsiveness to But Not the Release of Counterregulatory Hormones during Subsequent Hypoglycemia
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5462 - 5467.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
H. V. Jorgensen, U. Pedersen-Bjergaard, A. K. Rasmussen, and K. Borch-Johnsen
The Impact of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia on Relatives of Patients With Type 1 Diabetes
Diabetes Care, April 1, 2003; 26(4): 1106 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Korytkowski, A. Thomas, L. Reid, M. B. Tedesco, W. E. Gooding, and J. Gerich
Glimepiride Improves Both First and Second Phases of Insulin Secretion in Type 2 Diabetes
Diabetes Care, September 1, 2002; 25(9): 1607 - 1611.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. M. Ryan, D. Dulay, C. Suprasongsin, and D. J. Becker
Detection of Symptoms by Adolescents and Young Adults With Type 1 Diabetes During Experimental Induction of Mild Hypoglycemia: Role of hormonal and psychological variables
Diabetes Care, May 1, 2002; 25(5): 852 - 858.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Fruehwald-Schultes, W. Kern, K. M. Oltmanns, S. Sopke, B. Toschek, J. Born, H. L. Fehm, and A. Peters
Metformin Does Not Adversely Affect Hormonal and Symptomatic Responses to Recurrent Hypoglycemia
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4187 - 4192.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Fritsche, M. Stumvoll, H. U. Häring, and J. E. Gerich
Reversal of Hypoglycemia Unawareness in a Long-Term Type 1 Diabetic Patient by Improvement of {beta}-Adrenergic Sensitivity after Prevention of Hypoglycemia
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 523 - 525.
[Abstract] [Full Text]


Home page
JAMAHome page
M. R. Burge, K. Schmitz-Fiorentino, C. Fischette, C. R. Qualls, and D. S. Schade
A Prospective Trial of Risk Factors for Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus
JAMA, January 14, 1998; 279(2): 137 - 143.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. F. Veneman and D. W. Erkelens
Hypoglycemia Unawareness in Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1682 - 1684.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1994 by the American Diabetes Association.